|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.2 HKD | +1.59% |
|
-5.60% | -36.00% |
| 29/03 | Immunotech Biopharm Posts Nearly 335 Million Yuan Loss in 2023 | MT |
| 28/03 | Immunotech Biopharm Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Immunotech Biopharm Ltd reported earnings results for the half year ended June 30, 2022. For the half year, the company reported net loss was CNY 140.33 million compared to CNY 147.3 million a year ago. Basic loss per share from continuing operations was CNY 0.27 compared to CNY 0.29 a year ago.
Diluted loss per share from continuing operations was CNY 0.27 compared to CNY 0.29 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -36.00% | 211M | |
| +9.42% | 115B | |
| +11.84% | 106B | |
| -1.05% | 21.96B | |
| -14.15% | 21.84B | |
| -5.29% | 19.21B | |
| -4.16% | 18.08B | |
| -38.29% | 17.71B | |
| +7.99% | 14.32B | |
| +36.24% | 12.42B |
IMMUNOTECH BIOPHARM LTD 